Yes, but: 23% is still significant weight loss and Novo chief scientific officer Martin Holst Lange said "we are pleased with" that result
Compounded preparations are legally prepared by licensed pharmacies under section 503A for patient-specific use but arent FDA-approved as finished products
Deo SV, Marsia S, McAllister DA, Elgudin Y, Sattar N, Pell JP
As a partner of Bejing Peptide, Medicilon provides pharmacodynamics services to ZT002 that comply with the application in China, US and Australia
When to Seek Medical Advice : Patients should contact their healthcare provider if they experience unexplained bone pain, height loss, or fractures with minimal trauma, as these may indicate significant bone loss requiring evaluation and intervention
Can be tender to the touch